FDA-Inspected Site

Nahlah Seaplus, Inc.

9 FDA inspections are on record for Nahlah Seaplus, Inc. in Los Angeles, United States.

483· Form 483 issued

Los Angeles, United States · Last updated July 10, 2026

Overview

  • 9 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-04-24.

At a glance

Inspections

9

Form 483s

3

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
23 Apr 2024 – 24 Apr 2024Foods & Cosmetics483View 483 →
31 Jul 2019 – 1 Aug 2019Foods & Cosmetics483View 483 →
27 Sep 2016 – 28 Sep 2016Foods & Cosmetics483View 483 →
29 Feb 2012Not recordedClean
17 Oct 2011Not recordedClean
30 Mar 2009Not recordedClean
17 Sep 2008Not recordedClean
14 Jan 2003Not recordedClean
25 Sep 2001Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

24 Apr 2024
21 CFR 123.12(a)(2)

Importer verification

Cited by Lilly O Barton

24 Apr 2024
21 CFR 123.6(b)

No HACCP plan

Cited by Lilly O Barton

1 Aug 2019
21 CFR 123.12(a)(2)

Importer verification

Cited by Kimberly M Lichter

1 Aug 2019
21 CFR 123.6(b)

HACCP plan implementation

Cited by Kimberly M Lichter

1 Aug 2019
21 CFR 123.6(b)

No HACCP plan

Cited by Kimberly M Lichter

Investigators

FDA investigators tied to this site in the record.

CntrctMntr Davis2 insp.
Cntrctmntr Nepsa2 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 123.6(b)Cited across public-safe Form 483 observations3x
21 CFR 123.12(a)(2)Cited across public-safe Form 483 observations2x
21 CFR 110.20(a)(1)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Nahlah Seaplus, Inc.'s 3 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat